FDA Authorizes Marketing of
Tobacco- and Menthol-Flavored JUUL E-Cigarette Products

On July 17, 2025, the U.S. Food and Drug Administration (FDA) authorized the marketing of five JUUL e-cigarette products through the premarket tobacco product application (PMTA) pathway. The JUUL products now authorized for sale in the United States include the JUUL electronic device, Virginia Tobacco flavor JUULpods (3% and 5% nicotine concentration) and Menthol flavor JUULpods (3% and 5% nicotine concentration).

Following an extensive scientific review, the FDA determined that evidence provided by JUUL Labs – including new information the company submitted in response to a deficiency letter from the FDA – demonstrated that these specific products meet the legal standard set by the 2009 Family Smoking Prevention and Tobacco Control Act to market new tobacco products in the United States.

The FDA’s updated list of 39 authorized electronic cigarette products, including the new JUUL product authorizations, can be found here.

To read the complete FDA announcement regarding the authorization of the JUUL electronic cigarette products, click here.

For more information, please contact Kathee Facchiano at kfacchiano@capitoldecisions.com, Sarah Herbert at sherbert@capitoldecisions.com, or Tom Briant at tomb@cdaweb.net.